Corrigendum to “Dysregulated lipids homeostasis disrupts CHAC1-mediated ferroptosis driving fibroblast growth factor receptor tyrosine kinase inhibitor AZD4547 resistance in gastric cancer” [Redox Biol. 84 (2025) 103693]
Saved in:
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-09-01
|
| Series: | Redox Biology |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2213231725002411 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849227022629339136 |
|---|---|
| author | Jingwen Chen Yedi Huang Daocheng Zuo Ruimin Shan Songmao Li Ran Li Dong Hua Qiang Zhan Xudong Song Yun Chen Pei Ma Ling Ma Guoquan Tao Yongqian Shu |
| author_facet | Jingwen Chen Yedi Huang Daocheng Zuo Ruimin Shan Songmao Li Ran Li Dong Hua Qiang Zhan Xudong Song Yun Chen Pei Ma Ling Ma Guoquan Tao Yongqian Shu |
| author_sort | Jingwen Chen |
| collection | DOAJ |
| format | Article |
| id | doaj-art-9dfdcc202a004344aa71dc2b1f77e415 |
| institution | Kabale University |
| issn | 2213-2317 |
| language | English |
| publishDate | 2025-09-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Redox Biology |
| spelling | doaj-art-9dfdcc202a004344aa71dc2b1f77e4152025-08-24T05:12:21ZengElsevierRedox Biology2213-23172025-09-018510372810.1016/j.redox.2025.103728Corrigendum to “Dysregulated lipids homeostasis disrupts CHAC1-mediated ferroptosis driving fibroblast growth factor receptor tyrosine kinase inhibitor AZD4547 resistance in gastric cancer” [Redox Biol. 84 (2025) 103693]Jingwen Chen0Yedi Huang1Daocheng Zuo2Ruimin Shan3Songmao Li4Ran Li5Dong Hua6Qiang Zhan7Xudong Song8Yun Chen9Pei Ma10Ling Ma11Guoquan Tao12Yongqian Shu13Department of Oncology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, 210029, PR China; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, 211166, PR ChinaDepartment of Immunology, School of Basic Medical Sciences, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Nanjing Medical University, Nanjing, 210000, PR China; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, 211166, PR ChinaDepartment of Immunology, School of Basic Medical Sciences, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Nanjing Medical University, Nanjing, 210000, PR ChinaDepartment of Immunology, School of Basic Medical Sciences, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Nanjing Medical University, Nanjing, 210000, PR ChinaDepartment of Immunology, School of Basic Medical Sciences, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Nanjing Medical University, Nanjing, 210000, PR ChinaDepartment of Immunology, School of Basic Medical Sciences, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Nanjing Medical University, Nanjing, 210000, PR ChinaThe Affiliated Wuxi People's Hospital of Nanjing Medical University, School of Medicine, Jiangnan University, Wuxi, 214000, PR ChinaDepartments of Gastroenterology, The Affiliated Wuxi People's Hospital of Nanjing Medical University & Department of Medical Genetics, Nanjing Medical University, Nanjing, 210000, PR ChinaDepartment of Gastrointestinal Surgery, The Affiliated Huaian No. 1 People's Hospital of Nanjing Medical University, Huaian, 223300, PR ChinaDepartment of Immunology, School of Basic Medical Sciences, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Nanjing Medical University, Nanjing, 210000, PR China; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, 211166, PR China; Corresponding author. Department of Immunology, School of Basic Medical Sciences, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Nanjing Medical University, Nanjing, 210000, PR China.Department of Oncology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, 210029, PR China; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, 211166, PR China; Corresponding author. Department of Oncology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, 210029, PR China.Department of Oncology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, 210029, PR China; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, 211166, PR China; Corresponding author. Department of Oncology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, 210029, PR China.Department of Gastrointestinal Surgery, The Affiliated Huaian No. 1 People's Hospital of Nanjing Medical University, Huaian, 223300, PR ChinaDepartment of Oncology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, 210029, PR China; Gusu School, Nanjing Medical University, Suzhou, 211166, PR China; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, 211166, PR China; Corresponding author. Department of Oncology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, 210029, PR China.http://www.sciencedirect.com/science/article/pii/S2213231725002411 |
| spellingShingle | Jingwen Chen Yedi Huang Daocheng Zuo Ruimin Shan Songmao Li Ran Li Dong Hua Qiang Zhan Xudong Song Yun Chen Pei Ma Ling Ma Guoquan Tao Yongqian Shu Corrigendum to “Dysregulated lipids homeostasis disrupts CHAC1-mediated ferroptosis driving fibroblast growth factor receptor tyrosine kinase inhibitor AZD4547 resistance in gastric cancer” [Redox Biol. 84 (2025) 103693] Redox Biology |
| title | Corrigendum to “Dysregulated lipids homeostasis disrupts CHAC1-mediated ferroptosis driving fibroblast growth factor receptor tyrosine kinase inhibitor AZD4547 resistance in gastric cancer” [Redox Biol. 84 (2025) 103693] |
| title_full | Corrigendum to “Dysregulated lipids homeostasis disrupts CHAC1-mediated ferroptosis driving fibroblast growth factor receptor tyrosine kinase inhibitor AZD4547 resistance in gastric cancer” [Redox Biol. 84 (2025) 103693] |
| title_fullStr | Corrigendum to “Dysregulated lipids homeostasis disrupts CHAC1-mediated ferroptosis driving fibroblast growth factor receptor tyrosine kinase inhibitor AZD4547 resistance in gastric cancer” [Redox Biol. 84 (2025) 103693] |
| title_full_unstemmed | Corrigendum to “Dysregulated lipids homeostasis disrupts CHAC1-mediated ferroptosis driving fibroblast growth factor receptor tyrosine kinase inhibitor AZD4547 resistance in gastric cancer” [Redox Biol. 84 (2025) 103693] |
| title_short | Corrigendum to “Dysregulated lipids homeostasis disrupts CHAC1-mediated ferroptosis driving fibroblast growth factor receptor tyrosine kinase inhibitor AZD4547 resistance in gastric cancer” [Redox Biol. 84 (2025) 103693] |
| title_sort | corrigendum to dysregulated lipids homeostasis disrupts chac1 mediated ferroptosis driving fibroblast growth factor receptor tyrosine kinase inhibitor azd4547 resistance in gastric cancer redox biol 84 2025 103693 |
| url | http://www.sciencedirect.com/science/article/pii/S2213231725002411 |
| work_keys_str_mv | AT jingwenchen corrigendumtodysregulatedlipidshomeostasisdisruptschac1mediatedferroptosisdrivingfibroblastgrowthfactorreceptortyrosinekinaseinhibitorazd4547resistanceingastriccancerredoxbiol842025103693 AT yedihuang corrigendumtodysregulatedlipidshomeostasisdisruptschac1mediatedferroptosisdrivingfibroblastgrowthfactorreceptortyrosinekinaseinhibitorazd4547resistanceingastriccancerredoxbiol842025103693 AT daochengzuo corrigendumtodysregulatedlipidshomeostasisdisruptschac1mediatedferroptosisdrivingfibroblastgrowthfactorreceptortyrosinekinaseinhibitorazd4547resistanceingastriccancerredoxbiol842025103693 AT ruiminshan corrigendumtodysregulatedlipidshomeostasisdisruptschac1mediatedferroptosisdrivingfibroblastgrowthfactorreceptortyrosinekinaseinhibitorazd4547resistanceingastriccancerredoxbiol842025103693 AT songmaoli corrigendumtodysregulatedlipidshomeostasisdisruptschac1mediatedferroptosisdrivingfibroblastgrowthfactorreceptortyrosinekinaseinhibitorazd4547resistanceingastriccancerredoxbiol842025103693 AT ranli corrigendumtodysregulatedlipidshomeostasisdisruptschac1mediatedferroptosisdrivingfibroblastgrowthfactorreceptortyrosinekinaseinhibitorazd4547resistanceingastriccancerredoxbiol842025103693 AT donghua corrigendumtodysregulatedlipidshomeostasisdisruptschac1mediatedferroptosisdrivingfibroblastgrowthfactorreceptortyrosinekinaseinhibitorazd4547resistanceingastriccancerredoxbiol842025103693 AT qiangzhan corrigendumtodysregulatedlipidshomeostasisdisruptschac1mediatedferroptosisdrivingfibroblastgrowthfactorreceptortyrosinekinaseinhibitorazd4547resistanceingastriccancerredoxbiol842025103693 AT xudongsong corrigendumtodysregulatedlipidshomeostasisdisruptschac1mediatedferroptosisdrivingfibroblastgrowthfactorreceptortyrosinekinaseinhibitorazd4547resistanceingastriccancerredoxbiol842025103693 AT yunchen corrigendumtodysregulatedlipidshomeostasisdisruptschac1mediatedferroptosisdrivingfibroblastgrowthfactorreceptortyrosinekinaseinhibitorazd4547resistanceingastriccancerredoxbiol842025103693 AT peima corrigendumtodysregulatedlipidshomeostasisdisruptschac1mediatedferroptosisdrivingfibroblastgrowthfactorreceptortyrosinekinaseinhibitorazd4547resistanceingastriccancerredoxbiol842025103693 AT lingma corrigendumtodysregulatedlipidshomeostasisdisruptschac1mediatedferroptosisdrivingfibroblastgrowthfactorreceptortyrosinekinaseinhibitorazd4547resistanceingastriccancerredoxbiol842025103693 AT guoquantao corrigendumtodysregulatedlipidshomeostasisdisruptschac1mediatedferroptosisdrivingfibroblastgrowthfactorreceptortyrosinekinaseinhibitorazd4547resistanceingastriccancerredoxbiol842025103693 AT yongqianshu corrigendumtodysregulatedlipidshomeostasisdisruptschac1mediatedferroptosisdrivingfibroblastgrowthfactorreceptortyrosinekinaseinhibitorazd4547resistanceingastriccancerredoxbiol842025103693 |